| Autor: |
Liu S; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China., Yang H; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China., Heng X; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China., Yao L; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China., Sun W; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China., Zheng Q; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China., Wu Z; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China., Chen H; College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China. |
| Abstrakt: |
To effectively solve the problem of significant loss of transplanted cells caused by thrombosis during cell transplantation, this study simulates the human fibrinolytic system and combines metabolic oligosaccharide engineering with strain-promoted azide-alkyne cycloaddition (SPAAC) click chemistry to construct a cell surface with fibrinolytic activity. First, a copolymer (POL) of oligoethylene glycol methacrylate (OEGMA) and 6-amino-2-(2-methylamido)hexanoic acid (Lys) was synthesized by reversible addition-fragmentation chain transfer (RAFT) copolymerization, and the dibenzocyclooctyne (DBCO) functional group was introduced into the side chain of the copolymer through an active ester reaction, resulting in a functionalized copolymer DBCO-PEG4-POL with ε-lysine ligands. Then, azide functional groups were introduced onto the surface of HeLa model cells through metabolic oligosaccharide engineering, and DBCO-PEG4-POL was further specifically modified onto the surface of HeLa cells via the SPAAC "click" reaction. In vitro investigations revealed that compared with unmodified HeLa cells, modified cells not only resist the adsorption of nonspecific proteins such as fibrinogen and human serum albumin but also selectively bind to plasminogen in plasma while maintaining good cell viability and proliferative activity. More importantly, upon the activation of adsorbed plasminogen into plasmin, the modified cells exhibited remarkable fibrinolytic activity and were capable of promptly dissolving the primary thrombus formed on their surfaces. This research not only provides a novel approach for constructing transplantable cells with fibrinolytic activity but also offers a new perspective for effectively addressing the significant loss of transplanted cells caused by thrombosis. |
